Related Experiment Video
Updated: Jul 20, 2025

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
RASopathies and cardiac manifestations
Nazia Hilal1,2,3, Zi Chen2,4, Ming Hui Chen2,5
1Division of Genetics and Genomics, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States.
RAS proteins act as on/off switches, but mutations cause RASopathies, leading to developmental disorders and heart conditions. Understanding RAS regulation is key to diagnosing and treating these complex genetic syndromes.
Area of Science:
- Molecular Biology
- Genetics
- Developmental Biology
Background:
- RAS proteins function as binary switches, cycling between ON/OFF states for cellular signaling.
- Mutations in RAS or its regulators lead to constitutive activation, causing diseases like cancer and RASopathies.
- RAS/MAPK pathway genes are crucial for cell cycle, proliferation, differentiation, growth, and metabolism.
Purpose of the Study:
- To elucidate the regulatory mechanisms of RAS proteins.
- To clarify the link between RASopathies and cardiovascular conditions like cardiomyopathy and congenital heart disease.
- To address diagnostic challenges posed by genetic heterogeneity and allelism in RAS/MAPK syndromes.
Main Methods:
- Review of existing literature on RAS protein regulation and RASopathies.
- Analysis of genetic data related to RAS/MAPK pathway mutations.
- Examination of clinical manifestations, including cardiovascular defects, in RASopathy patients.
Main Results:
- RASopathies, caused by germline mutations in the RAS/MAPK pathway, affect 1 in 1,000-2,500 children.
- Syndromes include Noonan syndrome, cardio-facio-cutaneous syndrome, Costello syndrome, and LEOPARD syndrome.
- RASopathies are frequently associated with cardiomyopathy and congenital heart disease, though evidence is still developing.
Conclusions:
- Despite progress, the precise regulatory mechanisms of RAS proteins remain incompletely understood.
- Genetic complexity and allelism complicate the diagnosis of RAS/MAPK-related disorders.
- Unidentified causal genes persist for a significant number of RASopathy patients, highlighting the need for further research.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Cardiomyopathy IV: Restrictive Cardiomyopathy
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy I: Introduction and Classification

